Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFA, deworming, and nutrition education for anemia in Liberian adolescent girls
NCT05073562Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of iron + folic acid and mebendazole in nutritional anemia, iron deficiency anemia (IDA), Folate-deficiency anemia and 1 more, sponsored by Boston Children's Hospital. Primary endpoint: Hemoglobin level at Week 12. Planned start Oct 2021; status: withdrawn.
02
Drugs
iron + folic acidmebendazole
03
Conditions
nutritional anemiairon deficiency anemia (IDA)Folate-deficiency anemiahelminthiasis
Beyond the preview
Go deeper on NCT05073562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073562.